Paragon 28 Inc

Paragon 28 Inc(FNA)の株式分析

$13.090

0.000 (0.00%)終値時点

Loading chart…
High
13.110
Open
13.090
VWAP
13.09
Vol
19.38M
Mkt Cap
551.63M
Low
13.065
Amount
253.69M
EV/EBITDA, TTM
238.72

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.

paragon28.com

バリュエーション指標

The current forward P/E ratio for Paragon 28 Inc (FNA) is -27.89, compared to its 5-year average forward P/E of -39.31.

Forward P/E

Fair
5Y Average P/E
-39.31
Current P/E
-27.89
割高
-17.17
割安
-61.45

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
1.10
Current EV/EBITDA
238.72
割高
714.20
割安
-712.00

Forward P/S

Fair
5Y Average P/S
5.26
Current P/S
3.75
割高
7.45
割安
3.07

FNA FAQ — answered by Alphio AI

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める